Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | F2R | P25116 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.39 |
| ▸ | BTK | Q06187 | 1/20 | 0.38 |
| ▸ | ITK | Q08881 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | NQO2 | P16083 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24679668 | 0.83 | PTPN1 (0.42) | KMT2AMEN1POLBKDM4ENPC1 | |
| SCHEMBL23228136 | 0.72 | MGLL (0.59) | MGLLPOLBADORA3CNR1KDM4E | |
| SCHEMBL14402892 | 0.72 | TGM2 (0.48) | KMT2APOLBKDM4ENPC1RAB9A | |
| SCHEMBL20762752 | 0.71 | MAPT (0.47) | MGLLKMT2AMEN1POLBF2R | |
| SCHEMBL18473288 | 0.70 | MGLL (0.61) | MGLLKMT2AMEN1POLBADORA3 | |
| SCHEMBL20682568 | 0.68 | KMO (0.36) | KMT2AMEN1POLBADORA3KDM4E | |
| SCHEMBL20682556 | 0.68 | KMO (0.37) | KMT2AMEN1ADORA3KDM4E | |
| SCHEMBL18152289 | 0.67 | MEN1 (0.73) | MGLLKMT2AMEN1POLBF2R | |
| SCHEMBL14235979 | 0.67 | MAPT (0.52) | KMT2AMEN1BTKITKKDM4E | |
| SCHEMBL20870051 | 0.67 | MGLL (0.61) | MGLLKMT2AMEN1POLBADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11527721-B2 | Electroactive materials | LG CHEM, LTD. | 2022-12-13 | — | — | US | disclosed |
| US-20190181344-A1 | ELECTROACTIVE MATERIALS | LG CHEM, LTD. (KR) | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190181344-A1 | ELECTROACTIVE MATERIALS | NR5A1, AR, NR3C2 | MGLL 4807/4885KMT2A 1984/4885MEN1 1046/4885 |
| US-11527721-B2 | Electroactive materials | NR5A1, AR, NR3C2 | MGLL 4807/4885KMT2A 1984/4885MEN1 1046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.